Your browser doesn't support javascript.
loading
European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma.
Concin, Nicole; Planchamp, François; Abu-Rustum, Nadeem R; Ataseven, Beyhan; Cibula, David; Fagotti, Anna; Fotopoulou, Christina; Knapp, Pawel; Marth, Christian; Morice, Philippe; Querleu, Denis; Sehouli, Jalid; Stepanyan, Artem; Taskiran, Cagatay; Vergote, Ignace; Wimberger, Pauline; Zapardiel, Ignacio; Persson, Jan.
Afiliação
  • Concin N; Department of Gynecology and Obstetrics; Innsbruck Medical Univeristy, Innsbruck, Austria nicole.concin@i-med.ac.at.
  • Planchamp F; Department of Gynecology and Gynecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany.
  • Abu-Rustum NR; Clinical Research Unit, Institut Bergonie, Bordeaux, France.
  • Ataseven B; Department of Obstetrics and Gynecology, Memorial Sloann Kettering Cancer Center, New York, New York, USA.
  • Cibula D; Department of Gynecology and Gynecological Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany.
  • Fagotti A; Department of Obstetrics and Gynaecology, University Hospital Munich (LMU), Munich, Germany.
  • Fotopoulou C; Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czech Republic.
  • Knapp P; Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio, Italy.
  • Marth C; Department of Gynaecologic Oncology, Imperial College London Faculty of Medicine, London, UK.
  • Morice P; Department of Gynaecology and Gynaecologic Oncology, University Oncology Center of Bialystok, Medical University of Bialystok, Bialystok, Poland.
  • Querleu D; Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria.
  • Sehouli J; Department of Surgery, Institut Gustave Roussy, Villejuif, France.
  • Stepanyan A; Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio, Italy.
  • Taskiran C; Department of Obstetrics and Gynecologic Oncology, University Hospitals Strasbourg, Strasbourg, Alsace, France.
  • Vergote I; Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universitätzu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Wimberger P; Department of Gynecologic Oncology, Nairi Medical Center, Yerevan, Armenia.
  • Zapardiel I; Department of Obstetrics and Gynecology, Koç University School of Medicine, Ankara, Turkey.
  • Persson J; Department of Gynecologic Oncology, VKV American Hospital, Istambul, Turkey.
Int J Gynecol Cancer ; 31(12): 1508-1529, 2021 12.
Article em En | MEDLINE | ID: mdl-34795020
BACKGROUND: Quality of surgical care as a crucial component of a comprehensive multi-disciplinary management improves outcomes in patients with endometrial carcinoma, notably helping to avoid suboptimal surgical treatment. Quality indicators (QIs) enable healthcare professionals to measure their clinical management with regard to ideal standards of care. OBJECTIVE: In order to complete its set of QIs for the surgical management of gynecological cancers, the European Society of Gynaecological Oncology (ESGO) initiated the development of QIs for the surgical treatment of endometrial carcinoma. METHODS: QIs were based on scientific evidence and/or expert consensus. The development process included a systematic literature search for the identification of potential QIs and documentation of the scientific evidence, two consensus meetings of a group of international experts, an internal validation process, and external review by a large international panel of clinicians and patient representatives. QIs were defined using a structured format comprising metrics specifications, and targets. A scoring system was then developed to ensure applicability and feasibility of a future ESGO accreditation process based on these QIs for endometrial carcinoma surgery and support any institutional or governmental quality assurance programs. RESULTS: Twenty-nine structural, process and outcome indicators were defined. QIs 1-5 are general indicators related to center case load, training, experience of the surgeon, structured multi-disciplinarity of the team and active participation in clinical research. QIs 6 and 7 are related to the adequate pre-operative investigations. QIs 8-22 are related to peri-operative standards of care. QI 23 is related to molecular markers for endometrial carcinoma diagnosis and as determinants for treatment decisions. QI 24 addresses the compliance of management of patients after primary surgical treatment with the standards of care. QIs 25-29 highlight the need for a systematic assessment of surgical morbidity and oncologic outcome as well as standardized and comprehensive documentation of surgical and pathological elements. Each QI was associated with a score. An assessment form including a scoring system was built as basis for ESGO accreditation of centers for endometrial cancer surgery.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Indicadores de Qualidade em Assistência à Saúde / Oncologia Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Indicadores de Qualidade em Assistência à Saúde / Oncologia Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article